A phase 1 trial of TG-1701 (SHR-1459) in China.

Trial Profile

A phase 1 trial of TG-1701 (SHR-1459) in China.

Phase of Trial: Phase I

Latest Information Update: 12 Jan 2018

At a glance

  • Drugs SHR-1459 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Sponsors Jiangsu Hengrui Medicine Co.
  • Most Recent Events

    • 12 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top